FDA Inspection 1220721 — Rebecca F. Dunsmoor-Su, M.D.
The FDA completed an inspection of Rebecca F. Dunsmoor-Su, M.D. on Oct 6, 2023 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 6, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Seattle, WA (United States)
Additional details
Clinical Investigator (CI)